Earnings call transcript: Gruma posts mixed Q2 2026 results as U.S. weakens

Gruma reported 2Q26 consolidated sales up 3% YoY but volumes down 1% and EBITDA down 5% YoY, with the U.S. remaining the main drag (U.S. sales -3%, U.S. EBITDA -15%). Management cut 2026 guidance, expecting U.S. subsidiary volume and revenue to decline in the low single digits and an ~200 bps EBITDA margin contraction (consolidated: fractional declines in volume/revenue and ~160 bps EBITDA margin contraction), citing weak U.S. consumer demand and mix/margin pressure from higher private-label penetration. International results partially offset the weakness (e.g., Asia & Oceania sales +15% and EBITDA +47%; Europe EBITDA +17%), while leverage is expected to ease to ~1.3x by year-end. Shares were flat at $16.42, suggesting investors are waiting for margin stabilization, amid broader cost pressure tied to oil surging after a Houthi attack on Saudi tankers.

Analysis

The real issue is not a bad quarter; it is that the U.S. business is losing operating leverage at the same time the mix is shifting toward lower-margin private label and away from food service. That combination is structurally more damaging than a simple volume dip because it compresses EBITDA faster than revenue, and it makes any freight/fuel spike disproportionately painful for a distributor-heavy model. If oil remains elevated, the second-order hit is higher inbound logistics and packaging inflation, which could keep gross margin under pressure even if demand stabilizes.

The near-term catalyst is whether the third quarter merely marks a better comp base or an actual inflection in unit trends. A stabilization in food service runoff helps optics, but it does not solve the margin issue unless branded retail re-accelerates faster than private label penetration. Over the next 1-3 months, any additional guide cut or evidence that U.S. EBITDA margin is still deteriorating would likely overwhelm the balance-sheet/buyback story; over 6-18 months, the upside case depends on a consumer rebound that management cannot time and that the market should not pay for today.

Contrarianly, the market may be underweight the diversification and buyback support, but I think it is overestimating how quickly margin mix normalizes once private label wins shelf space. The more important tell is whether management can defend volume without permanently lowering economic value per unit; if not, buybacks will only slow multiple compression, not prevent it. This looks more like a patience trade than a cleanup story.

Key Decisions for Investors

• Trim/underweight GPAGF on strength over the next 2-6 weeks; the cleanest thesis is that consensus is still too optimistic on U.S. margin recovery. Falsifier: two consecutive months of improving U.S. food-service volumes and no further guidance pressure.
• Relative-value pair: long XLP / short GPAGF for 1-3 months to express defensiveness vs. a single-name margin reset. Target 5-8% relative underperformance in GPAGF if freight/oil stays elevated; stop if GPAGF reaffirms margins and volumes stabilize sequentially.
• If GPAGF sells off toward the 52-week low again, only add after management shows working-capital unwind is actually translating into lower net debt and that private-label mix is peaking. Risk/reward is poor before that because the next catalyst is still a guidance revision risk, not a rerating event.
• Watch the oil/freight tape as an earnings sensitivity for GPAGF over the next quarter; sustained Brent above $100 raises the probability of another 50-100 bp margin miss via distribution and packaging costs.